Business Description
GlycoMimetics Inc
NAICS : 325412
SIC : 2834
ISIN : US38000Q1022
Description
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 54.93 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -48.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 18 | |||||
| 3-Year EPS without NRI Growth Rate | 19.7 | |||||
| 3-Year FCF Growth Rate | 13.8 | |||||
| 3-Year Book Growth Rate | -38.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 55.33 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.46 | |||||
| 9-Day RSI | 41.98 | |||||
| 14-Day RSI | 48.49 | |||||
| 6-1 Month Momentum % | -36.81 | |||||
| 12-1 Month Momentum % | -89.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.62 | |||||
| Quick Ratio | 3.62 | |||||
| Cash Ratio | 3.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.5 | |||||
| Shareholder Yield % | 2.11 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -367840 | |||||
| Net Margin % | -397350 | |||||
| FCF Margin % | -356955.56 | |||||
| ROE % | -136.72 | |||||
| ROA % | -114.95 | |||||
| ROIC % | -1115.75 | |||||
| ROC (Joel Greenblatt) % | -4350.05 | |||||
| ROCE % | -126.28 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.78 | |||||
| Price-to-Tangible-Book | 1.71 | |||||
| EV-to-EBIT | -0.16 | |||||
| EV-to-EBITDA | -0.17 | |||||
| EV-to-Revenue | 606 | |||||
| EV-to-FCF | -0.17 | |||||
| Price-to-Net-Current-Asset-Value | 1.71 | |||||
| Price-to-Net-Cash | 1.94 | |||||
| Earnings Yield (Greenblatt) % | -625 | |||||
| FCF Yield % | -173.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlycoMimetics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.009 | ||
| EPS (TTM) (€) | -0.568 | ||
| Beta | 1.02 | ||
| Volatility % | 201.73 | ||
| 14-Day RSI | 48.49 | ||
| 14-Day ATR (€) | 0.028291 | ||
| 20-Day SMA (€) | 0.349225 | ||
| 12-1 Month Momentum % | -89.08 | ||
| 52-Week Range (€) | 0.126 - 3.19 | ||
| Shares Outstanding (Mil) | 64.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GlycoMimetics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GlycoMimetics Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
GlycoMimetics Inc Frequently Asked Questions
What is GlycoMimetics Inc(STU:GKO)'s stock price today?
The current price of STU:GKO is €0.29. The 52 week high of STU:GKO is €3.19 and 52 week low is €0.13.
When is next earnings date of GlycoMimetics Inc(STU:GKO)?
The next earnings date of GlycoMimetics Inc(STU:GKO) is 2025-03-27 Est..
Does GlycoMimetics Inc(STU:GKO) pay dividends? If so, how much?
GlycoMimetics Inc(STU:GKO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers